BRK-B vs CXE
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
CXE presents a stable Piotroski F-Score of 5/9, but this is overshadowed by severe valuation disconnects and unsustainable payout metrics. The stock trades at $3.74, vastly exceeding its Graham Number of $0.97 and an Intrinsic Value of $0.07. With a P/E ratio of 374.00 and a dividend payout ratio of 2070%, the current price is not supported by earnings or cash flow. Negative earnings growth (-16.5%) and a critical liquidity position (Current Ratio 0.27) further degrade the investment profile.
Compare Another Pair
Related Comparisons
BRK-B vs CXE: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and MFS High Income Municipal Trust (CXE) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.